Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of PROVEXIS PLC
No Price
Closing Price XLON 29.04.2026:
1,01 GBX
29.04.2026 09:59
Current Prices from PROVEXIS PLC
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
London
PXS.L
GBX
29.04.2026 09:59
1,01 GBX
-0,01 GBX
-1,22 %
Share Float & Liquidity
Free Float88,46 %
Shares Float2,08 B
Shares Outstanding2,35 B
Company Profile for PROVEXIS PLC Share
Provexis plc, together with its subsidiaries, develops, licenses, and markets functional foods, medical foods, and dietary supplements worldwide. Its products include Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke. The company's syrup and powder versions of Fruitflow are used in foods, beverages, and dietary supplement formats. It also offers Fruitflow + Omega-3, a supplement in capsule form that supports healthy blood flow and normal heart function. Provexis plc has a collaboration agreement with By-Health Co., Ltd. The company offers its products through retail stores, as well as online. Provexis plc was founded in 1999 and is based in Reading, the United Kingdom.
